Retatrutide

A20-2020 · Weight Management & Metabolic

What labs study it for

Metabolism and hormone-receptor research. Labs use it to study how one molecule can switch on three different hormone receptors at once (GLP-1, GIP and glucagon), and how that signalling plays out in cell and animal models of energy balance.

What this compound is

Retatrutide is a synthetic investigational peptide designed as a single molecule acting at three receptors: GIP, GLP-1 and glucagon. It is a long synthetic chain carrying a fatty-acid modification that extends its half-life. It is investigational, has not been approved by any regulatory authority anywhere in the world, and is supplied strictly as a laboratory reagent.

Retatrutide. Supplied lyophilized. Lot-specific HPLC and MS documentation accompanies each unit.

Family

All families →

Incretin-receptor agonists

One molecule engineered to act at several metabolic receptors at once.

Incretins are gut hormones released after eating that act on receptors regulating metabolism. A long-running line of research has built synthetic peptides that activate more than one of these receptors from a single molecule. Retatrutide is a triple agonist — GIP, GLP-1 and glucagon receptors together — and carries a fatty-acid modification that extends its half-life. It is investigational and has not been approved by any regulatory authority.

Fields of study

Receptor pharmacology
Incretin signalling
Metabolic regulation models

Specifications

Catalog number	A20-2020
CAS number	2381089-83-2
Molecular formula	C221H342N46O68
Molecular weight	4731.33 g/mol
Purity (HPLC)	≥ 99.0 %
Physical form	Lyophilized powder
Storage	-20 C, desiccated, protected from light

Reference information for laboratory research only — not for human or veterinary use.